3,376
Views
18
CrossRef citations to date
0
Altmetric
Research Article

The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines

, , ORCID Icon, , , , , ORCID Icon, , , ORCID Icon, & ORCID Icon show all
Article: 1771142 | Received 30 Mar 2020, Accepted 15 May 2020, Published online: 01 Jun 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Inés Lecoq, Katharina L. Kopp, Marion Chapellier, Panagiotis Mantas, Evelina Martinenaite, Maria Perez-Penco, Lars Rønn Olsen, Mai-Britt Zocca, Ayako Wakatsuki Pedersen & Mads Hald Andersen. (2022) CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment. OncoImmunology 11:1.
Read now
Simone Kloch Bendtsen, Maria Perez-Penco, Mie Linder Hübbe, Evelina Martinenaite, Morten Orebo Holmström, Stine Emilie Weis-Banke, Nicolai Grønne Dahlager Jørgensen, Mia Aaboe Jørgensen, Shamaila Munir Ahmad, Kasper Mølgaard Jensen, Christina Friese, Mia Thorup Lundsager, Astrid Zedlitz Johansen, Marco Carretta, Niels Ødum, Özcan Met, Inge Marie Svane, Daniel Hargbøl Madsen & Mads Hald Andersen. (2022) Peptide vaccination activating Galectin-3-specific T cells offers a novel means to target Galectin-3-expressing cells in the tumor microenvironment. OncoImmunology 11:1.
Read now

Articles from other publishers (16)

Rasmus Erik Johansson Mortensen, Morten Orebo Holmström, Thomas Landkildehus Lisle, Jane P Hasselby, Gro L Willemoe, Özcan Met, Inge Marie Svane, Julia Johansen, Dorte L Nielsen, Inna M Chen & Mads Hald Andersen. (2023) Pre-existing TGF-β-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy. Journal for ImmunoTherapy of Cancer 11:3, pages e006432.
Crossref
Mads Hald Andersen. (2022) Tumor microenvironment antigens. Seminars in Immunopathology 45:2, pages 253-264.
Crossref
Maria Perez-Penco, Stine Emilie Weis-Banke, Aimilia Schina, Majken Siersbæk, Mie Linder Hübbe, Mia Aaboe Jørgensen, Inés Lecoq, Lucia Lara de la Torre, Simone Kloch Bendtsen, Evelina Martinenaite, Morten Orebo Holmström, Daniel Hargbøl Madsen, Marco Donia, Niels Ødum, Lars Grøntved & Mads Hald Andersen. (2022) TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer. Journal for ImmunoTherapy of Cancer 10:12, pages e005491.
Crossref
A. Giannoudis, D. Varešlija, V. Sharma, R. Zakaria, A. Platt-Higgins, P.S. Rudland, M.D. Jenkinson, L.S. Young & C. Palmieri. (2022) Characterisation of the immune microenvironment of primary breast cancer and brain metastasis reveals depleted T-cell response associated to ARG2 expression. ESMO Open 7:6, pages 100636.
Crossref
Zhuozhuo Li, Liwei Wang, Yuanyuan Ren, Yaoyao Huang, Wenxuan Liu, Ziwei Lv, Lu Qian, Yi Yu & Yuyan Xiong. (2022) Arginase: shedding light on the mechanisms and opportunities in cardiovascular diseases. Cell Death Discovery 8:1.
Crossref
Stine Emilie Weis-Banke, Thomas Landkildehus Lisle, Maria Perez-Penco, Aimilia Schina, Mie Linder Hübbe, Majken Siersbæk, Morten Orebo Holmström, Mia Aaboe Jørgensen, Inge Marie Svane, Özcan Met, Niels Ødum, Daniel Hargbøl Madsen, Marco Donia, Lars Grøntved & Mads Hald Andersen. (2022) Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells. Journal for ImmunoTherapy of Cancer 10:10, pages e005326.
Crossref
Marcin Mikołaj Grzybowski, Paulina Seweryna Stańczak, Paulina Pomper, Roman Błaszczyk, Bartłomiej Borek, Anna Gzik, Julita Nowicka, Karol Jędrzejczak, Joanna Brzezińska, Tomasz Rejczak, Nazan Cemre Güner-Chalimoniuk, Agnieszka Kikulska, Michał Mlącki, Jolanta Pęczkowicz-Szyszka, Jacek Olczak, Adam Gołębiowski, Karolina Dzwonek, Paweł Dobrzański & Zbigniew Zasłona. (2022) OATD-02 Validates the Benefits of Pharmacological Inhibition of Arginase 1 and 2 in Cancer. Cancers 14:16, pages 3967.
Crossref
Ana Caruntu, Liliana Moraru, Diana Alina Ciubotaru, Cristiana Tanase, Cristian Scheau & Constantin Caruntu. (2022) Assessment of Serum Urea, Creatinine and Uric Acid in Oral Cancer. Journal of Clinical Medicine 11:12, pages 3459.
Crossref
Fanglin Niu, Yi Yu, Zhuozhuo Li, Yuanyuan Ren, Zi Li, Qiang Ye, Ping Liu, Chenshuang Ji, Lu Qian & Yuyan Xiong. (2022) Arginase: An emerging and promising therapeutic target for cancer treatment. Biomedicine & Pharmacotherapy 149, pages 112840.
Crossref
Moufida Souid, Randa Ghedira, Sameh Souissi, Nadia Bouzgarrou, Sallouha Gabbouj, Salwa Shini-Hadhri, Mohamed-Saleh Rhim, Asma Boukadida, Dhekra Toumi, Raja Faleh, Noureddine Bouaouina, Abdelfatteh Zakhama & Elham Hassen. (2022) Arginase is involved in cervical lesions progression and severity. Immunobiology 227:2, pages 152189.
Crossref
Mia Aaboe Jørgensen, Stefano Ugel, Mie Linder Hübbe, Marco Carretta, Maria Perez-Penco, Stine Emilie Weis-Banke, Evelina Martinenaite, Katharina Kopp, Marion Chapellier, Annalisa Adamo, Francesco De Sanctis, Cristina Frusteri, Manuela Iezzi, Mai-Britt Zocca, Daniel Hargbøll Madsen, Ayako Wakatsuki Pedersen, Vincenzo Bronte & Mads Hald Andersen. (2021) Arginase 1–Based Immune Modulatory Vaccines Induce Anticancer Immunity and Synergize with Anti–PD-1 Checkpoint Blockade. Cancer Immunology Research 9:11, pages 1316-1326.
Crossref
Emma Hajaj, Marco Sciacovelli, Christian Frezza & Ayelet Erez. (2021) The context-specific roles of urea cycle enzymes in tumorigenesis. Molecular Cell 81:18, pages 3749-3759.
Crossref
Claire André & Yves Claude Guillaume. (2021) Development of a new nano arginase HPLC capillary column for the fast screening of arginase inhibitors and evaluation of their binding affinity. Journal of Chromatography B 1175, pages 122751.
Crossref
Jacob Handlos Grauslund, Morten Orebo Holmström, Nicolai Grønne Jørgensen, Uffe Klausen, Stine Emilie Weis-Banke, Daniel El Fassi, Claudia Schöllkopf, Mette Borg Clausen, Lise Mette Rahbek Gjerdrum, Marie Fredslund Breinholt, Julie Westerlin Kjeldsen, Morten Hansen, Steffen Koschmieder, Nicolas Chatain, Guy Wayne Novotny, Jesper Petersen, Lasse Kjær, Vibe Skov, Özcan Met, Inge Marie Svane, Hans Carl Hasselbalch & Mads Hald Andersen. (2021) Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms. Frontiers in Oncology 11.
Crossref
Morten Orebo Holmström, Rasmus Erik Johansson Mortensen, Angelos Michail Pavlidis, Evelina Martinenaite, Stine Emilie Weis-Banke, Mia Aaboe-Jørgensen, Simone Kloch Bendtsen, Özcan Met, Ayako Wakatsuki Pedersen, Marco Donia, Inge Marie Svane & Mads Hald Andersen. (2021) Cytotoxic T cells isolated from healthy donors and cancer patients kill TGFβ-expressing cancer cells in a TGFβ-dependent manner. Cellular & Molecular Immunology 18:2, pages 415-426.
Crossref
Mie Linder Hübbe, Ditte Elisabeth Jæhger, Thomas Lars Andresen & Mads Hald Andersen. (2020) Leveraging Endogenous Dendritic Cells to Enhance the Therapeutic Efficacy of Adoptive T-Cell Therapy and Checkpoint Blockade. Frontiers in Immunology 11.
Crossref